SEQUOIA A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CK-3773274 IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Cytokinetics, Inc.
Start Date
February 28, 2022
End Date
March 1, 2024
Administered By
Institutes and Centers
Awarded By
Cytokinetics, Inc.
Start Date
February 28, 2022
End Date
March 1, 2024